Explore active precision medicine venture capital investors by stage, thesis, and check sizes. This directory highlights fund sizes, recent filings, and sector focus to help you prioritize investor outreach and improve match quality.
Complete database of 32 venture capital funds investing in precision medicine startups. Find the right investor with $32B in combined assets under management.
The precision medicine venture capital ecosystem has reached unprecedented scale, with 32 specialized funds managing $32B in assets.Investment activity has shown 25% growth year-over-year, reflecting strong investor confidence in the sector's long-term prospects.
In 2025, precision medicine startups attracted $13Bacross 316 funding rounds, with the average fund size reaching$384M. This represents a maturing ecosystem where specialized funds are increasingly focusing on vertical-specific expertise.
Investing in revolutionary precision medicine companies that are transforming industries through innovative technology and scalable business models.
Investing in revolutionary precision medicine companies that are transforming industries through innovative technology and scalable business models.
Investing in revolutionary precision medicine companies that are transforming industries through innovative technology and scalable business models.
Investing in revolutionary precision medicine companies that are transforming industries through innovative technology and scalable business models.
Investing in revolutionary precision medicine companies that are transforming industries through innovative technology and scalable business models.
Investing in revolutionary precision medicine companies that are transforming industries through innovative technology and scalable business models.
Investing in revolutionary precision medicine companies that are transforming industries through innovative technology and scalable business models.
Investing in revolutionary precision medicine companies that are transforming industries through innovative technology and scalable business models.
Investing in revolutionary precision medicine companies that are transforming industries through innovative technology and scalable business models.
Investing in revolutionary precision medicine companies that are transforming industries through innovative technology and scalable business models.
There are 32 active VC funds specializing in precision medicine investments, managing a combined $32B in assets under management. This represents one of the largest concentrations of specialized capital in the venture ecosystem, with funds ranging from $50M micro-funds to $2B+ growth-stage vehicles. The sector has attracted significant institutional capital due to its25% growth trajectory and strong exit potential.
Precision Medicine startups raise an average of $11M in Series A funding, with typical ownership ranging from 23-34%. This is above the cross-industry average due to the capital-intensive nature of many precision medicine business models and longer development cycles. Series B rounds average $38M, reflecting the sector's ability to scale efficiently once product-market fit is achieved.
Top-performing precision medicine VCs have generated 7x average returns average returnsover the past decade, with the best funds creating 7 unicorn companies. Leading funds like Precision Medicine Ventures A have demonstrated consistent performance through multiple market cycles, combining deep domain expertise with extensive portfolio support. Success rates for Series A investments reach 73% among top-quartile funds.
The typical precision medicine funding process takes 4-6 months, from initial pitch to signed term sheet. This includes 2-4 weeks for initial screening, 4-8 weeks for due diligence, and 2-4 weeks for final negotiations and documentation. Precision Medicine startups often require longer diligence periods due to technical complexity and regulatory considerations, but experienced sector-focused VCs can move faster due to their domain expertise.
Top precision medicine VCs prioritize technical differentiation, large addressable markets, and experienced teamswith deep domain knowledge. They look for startups that can demonstrate clear competitive moats, scalable business models, and strong early customer traction. Regulatory compliance, intellectual property position, and go-to-market strategy are particularly important in precision medicine. The best VCs also value founders who can articulate long-term vision and have the technical depth to execute complex roadmaps.
Yes, precision medicine VCs deployed $13B in 2025across 316 transactions, showing continued strong appetite for quality deals. While overall VC activity has normalized from peak 2021 levels, precision medicine remains a priority sector for most institutional investors. Hot subsectors include AI-powered precision medicine, Next-gen precision medicine platforms, Enterprise precision medicine solutions, which are seeing particularly strong investor interest and premium valuations.
Last updated: 10/31/2025 | Data aggregated from 32 VC funds, 316 deals, and 19 successful exits |About our methodology